• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Assessing the Impact of Improvements in PASI and Itch Scores on Patients' Quality of Life in the Treatment of Psoriasis.

作者信息

Yosipovitch Gil, Dong Yan, Burge Russel, Zhu Baojin, Shrom David, Kimball Alexa B

机构信息

Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 33136 Miami, FL, USA.

出版信息

Acta Derm Venereol. 2019 Oct 1;99(11):1031-1032. doi: 10.2340/00015555-3254.

DOI:10.2340/00015555-3254
PMID:31290556
Abstract
摘要

相似文献

1
Assessing the Impact of Improvements in PASI and Itch Scores on Patients' Quality of Life in the Treatment of Psoriasis.评估银屑病治疗中银屑病面积和严重程度指数（PASI）及瘙痒评分的改善对患者生活质量的影响。
Acta Derm Venereol. 2019 Oct 1;99(11):1031-1032. doi: 10.2340/00015555-3254.
2
Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial.瘙痒是银屑病患者的一个严重问题，也是疾病严重程度和生活质量之间的中介：一项随机对照试验的结果。
Br J Dermatol. 2014 Nov;171(5):1215-9. doi: 10.1111/bjd.13065. Epub 2014 Oct 15.
3
Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials.依奇珠单抗对银屑病瘙痒严重程度和其他银屑病症状的影响：来自 3 项 III 期银屑病临床试验的结果。
J Am Acad Dermatol. 2016 Dec;75(6):1156-1161. doi: 10.1016/j.jaad.2016.07.034. Epub 2016 Sep 27.
4
Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension.司库奇尤单抗对银屑病瘙痒严重程度的长期影响：一项III期临床试验及长期扩展研究的结果
Acta Derm Venereol. 2018 Jan 12;98(1):98-102. doi: 10.2340/00015555-2801.
5
Absolute and Relative Psoriasis Area and Severity Indices (PASI) for Comparison of the Efficacy of Ixekizumab to Etanercept and Placebo in Patients with Moderate-to-severe Plaque Psoriasis: An Integrated Analysis of UNCOVER-2 and UNCOVER-3 Outcomes.用于比较依奇珠单抗与依那西普和安慰剂在中重度斑块状银屑病患者中的疗效的绝对和相对银屑病面积和严重程度指数（PASI）：UNCOVER-2 和 UNCOVER-3 结局的综合分析。
Acta Derm Venereol. 2019 Oct 1;99(11):971-977. doi: 10.2340/00015555-3245.
6
Rapid improvements in health-related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER-2 and UNCOVER-3.在随机 3 期临床试验中，依奇珠单抗治疗可迅速改善与健康相关的生活质量和瘙痒：UNCOVER-2 和 UNCOVER-3 的结果。
J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1483-1490. doi: 10.1111/jdv.14211. Epub 2017 Jun 28.
7
Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial.在一项随机、双盲的 3b 期临床试验中，与乌司奴单抗相比，接受依奇珠单抗治疗的中重度银屑病患者在 52 周时累积获益更大。
J Dermatolog Treat. 2020 Mar;31(2):141-146. doi: 10.1080/09546634.2019.1587146. Epub 2019 Mar 18.
8
Efficacy and safety of ixekizumab over 4 years of open-label treatment in a phase 2 study in chronic plaque psoriasis.在一项慢性斑块型银屑病的 2 期研究中，接受司库奇尤单抗开放性治疗 4 年的疗效和安全性。
J Am Acad Dermatol. 2018 Aug;79(2):294-301.e6. doi: 10.1016/j.jaad.2018.03.047. Epub 2018 Apr 10.
9
Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis.中重度斑块状银屑病患者瘙痒数字评分量表的心理测量特性。
Br J Dermatol. 2016 Jul;175(1):157-62. doi: 10.1111/bjd.14464. Epub 2016 May 8.
10
Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.在真实世界中接受生物制剂治疗的斑块状银屑病日本患者中，在开始或转换生物制剂时使用皮肤病生活质量指数的效用：来自 ProLOGUE 研究的结果。
J Dermatol Sci. 2021 Mar;101(3):185-193. doi: 10.1016/j.jdermsci.2021.01.002. Epub 2021 Jan 7.

引用本文的文献

1
Psychopathological Profile of Patients with Moderate-to-Severe Plaque Psoriasis and Its Correlation to DLQI: Results from a Prospective, Monocentric Clinical Study.中重度斑块状银屑病患者的精神病理学特征及其与皮肤病生活质量指数的相关性：一项前瞻性单中心临床研究的结果
J Clin Med. 2024 Oct 26;13(21):6424. doi: 10.3390/jcm13216424.
2
Itch as a critical factor in impaired health-related quality of life in patients with plaque psoriasis achieving clear or almost-clear skin: Analysis of the single-arm, open-label, multicenter, prospective ProLOGUE study.瘙痒作为斑块状银屑病患者皮肤达到清除或几乎清除时健康相关生活质量受损的关键因素：单臂、开放标签、多中心、前瞻性ProLOGUE研究分析
JAAD Int. 2022 Jun 22;8:146-153. doi: 10.1016/j.jdin.2022.06.013. eCollection 2022 Sep.
3
Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J).快速皮肤清除与生活质量改善之间的关系：司库奇尤单抗治疗中重度银屑病日本患者的事后分析（UNCOVER-J）
Dermatol Ther (Heidelb). 2020 Dec;10(6):1397-1404. doi: 10.1007/s13555-020-00441-4. Epub 2020 Sep 10.